Poor response to simvastatin in familial defective apo-B-100

Lancet. 1991 Feb 2;337(8736):305. doi: 10.1016/0140-6736(91)90920-k.
No abstract available

Publication types

  • Comparative Study
  • Letter

MeSH terms

  • Anticholesteremic Agents / metabolism*
  • Apolipoproteins B / genetics*
  • Humans
  • Hyperlipoproteinemia Type II / metabolism*
  • Lovastatin / analogs & derivatives*
  • Lovastatin / metabolism
  • Receptors, LDL / drug effects
  • Receptors, LDL / metabolism*
  • Simvastatin

Substances

  • Anticholesteremic Agents
  • Apolipoproteins B
  • Receptors, LDL
  • Lovastatin
  • Simvastatin